FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:886-887 March 30, 1995 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

During the two decades that followed the identification, in 1938, of cystic fibrosis as a distinct disease,¹ few patients lived past the age of five years. At that time, most patients with cystic fibrosis died of rapidly progressive pulmonary infections. Delayed diagnosis of the disease, malnutrition, and ineffective antibiotic therapy were among the most important factors contributing to the dismal prognosis for patients with this relatively common genetic disorder. The discovery of an abnormality in sweat electrolytes soon led to the development of a simple method to diagnose cystic fibrosis and, more recently, has resulted in an understanding of the . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.